⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GRCE News
Grace Therapeutics, Inc. Common Stock
Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update
globenewswire.com
GRCE
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
prnewswire.com
GRCE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Grace Therapeutics, Inc. (GRCE) And Encourages Shareholders to Connect
accessnewswire.com
GRCE
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Grace Therapeutics, Inc. (GRCE) And Encourages Shareholders to Reach Out
accessnewswire.com
GRCE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Grace Therapeutics, Inc. (GRCE) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
GRCE
GRCE Investors Have Opportunity to Join Grace Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
prnewswire.com
GRCE
Grace Therapeutics, Inc. (GRCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
GRCE
Grace Therapeutics, Inc. (GRCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
GRCE
Form 8-K
sec.gov
GRCE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Grace Therapeutics, Inc. (GRCE) And Encourages Investors to Connect
accessnewswire.com
GRCE